T. Hasse

1 ta ish

University Hospital Zurich

1. Benefit of Adjuvant Chemotherapy for Resected Pancreatic Cancer Following Neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: A Multinational Analysis

   V. Lopez Lopez, T. Hasse, E. Rangelova +18

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.116378